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Abstract
We tested if small conductance, Ca2 +‐sensitive K+ channels (SKCa) precondition hearts against ischemia
reperfusion (IR) injury by improving mitochondrial (m) bioenergetics, if O2‐derived free radicals are
required to initiate protection via SKCa channels, and, importantly, if SKCa channels are present in cardiac
cell inner mitochondrial membrane (IMM). NADH and FAD, superoxide (O2 −), and m[Ca2 +] were
measured in guinea pig isolated hearts by fluorescence spectrophotometry. SKCa and IKCa channel opener
DCEBIO (DCEB) was given for 10 min and ended 20 min before IR. Either TBAP, a dismutator of O2 −,
NS8593, an antagonist of SKCa isoforms, or other KCa and KATP channel antagonists, were given before
DCEB and before ischemia. DCEB treatment resulted in a 2-fold increase in LV pressure on reperfusion
and a 2.5 fold decrease in infarct size vs. non-treated hearts associated with reduced O2 − and m[Ca2 +],
and more normalized NADH and FAD during IR. Only NS8593 and TBAP antagonized protection by DCEB.
Localization of SKCa channels to mitochondria and IMM was evidenced by a) identification of purified
mSKCa protein by Western blotting, immuno-histochemical staining, confocal microscopy, and immunogold electron microscopy, b) 2-D gel electrophoresis and mass spectroscopy of IMM protein, c) [Ca2 +]‐
dependence of mSKCa channels in planar lipid bilayers, and d) matrix K+ influx induced by DCEB and

blocked by SKCa antagonist UCL1684. This study shows that 1) SKCa channels are located and functional in
IMM, 2) mSKCa channel opening by DCEB leads to protection that is O2 − dependent, and 3) protection by
DCEB is evident beginning during ischemia.

Graphical abstract

Abbreviations

IR, ischemia reperfusion; SKCa, small conductance Ca2 +‐sensitive K+ channel; BKCa, big conductance
Ca2+‐sensitive K+ channel; KATP, ATP‐sensitive K+ channel; DCEB5, 6-dichloro-1-ethyl-1,3-dihydro-2Hbenzimidazol-2-one; IMM, inner mitochondrial membrane; TBAP, Mn(III) tetrakis (4-benzoic acid)
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1. Introduction
Depressed mitochondrial (m) bioenergetics, excess reactive oxygen species (ROS) generation, and mCa2 +
loading are major factors underlying ischemia and reperfusion (IR) injury.1 Prophylactic measures
targeted in part to mitochondria that reduce cardiac IR injury2, 3 include ischemic preconditioning (IPC,
i.e., brief pulses of ischemia and reperfusion before longer ischemia) and pharmacologic preconditioning (PPC), i.e., cardiac protection elicited some time after the drug is washed out. PPC is
theoretically a better approach because it does not require the heart to first undergo brief ischemia. We
reported previously that activation of a large (big) conductance Ca2 +‐sensitive K+ channel (mBKCa), which
may be located in the cardiac myocyte inner mitochondrial membrane (IMM), can induce PPC.4 The BKCa
channel has not been found in the cardiac myocyte plasma membrane, but we have shown that a BKCa
channel opener, NS1619, has biphasic effects on mitochondrial respiration, membrane potential (∆Ψm),

and superoxide radical (O2 −) production in isolated mitochondria.5, 6 This suggested that opening of
other mitochondrial K+ channels could also elicit PPC.
There are other KCa channels of intermediate or small conductances identified in non-cardiac cells7, 8, 9, 10
that are membrane bound, calmodulin (CaM)‐dependent and gated by Ca2 + and other factors. These
channels have smaller unit conductances of 3–30 (small, SKCa) and 20–90 (intermediate IKCa) pS.11 The
opening of SKCa channels is initiated by Ca2 + binding to calmodulin at the C terminus of the channel,12,13
KCa2.3 is one of the known isoforms of SKCa channels that have been identified in endothelial cells; this
isoform was found to exert a potent, tonic hyperpolarization that reduced vascular smooth muscle
tone.14 Moreover, there is evidence for the KCa2.2 isoform in rat and human hearts using Western blot
analysis and reverse transcription‐polymerase chain reaction.15 Clones of the channel from atria and
ventricles showed much greater expression in atria compared to ventricles, and electrophysiological
recordings exhibited much greater atrial than ventricular sensitivity to AP repolarization by apamin, a
selective SKCa antagonist.15,16
We postulated that activation of SKCa channels induces a preconditioning effect similar to that elicited by
a BKCa (KCa1.1, maxi-K) opener, and that this effect is mediated via channels located in the IMM, i.e., they
promote K+ entry into the mitochondrial matrix. We tested if the KCa3.1 (IKCa1)7,9,17 and KCa2.2 and KCa2.3
(SKCa)18,19,20,21 opener DCEBIO (DCEB), given transiently before ischemia, elicits PPC in a manner similar to
that of the mBKCa channel opener NS1619.4 We specifically examined the role of DCEB in attenuating the
deleterious effects of IR injury on mitochondrial bioenergetics by near continuous measurement of
m[Ca2 +], NADH and FAD, and O2 − in isolated perfused hearts. We infused NS8593 to antagonize SKCa
channel opening.22,23 and several other K+ channel blockers to rule out effects of DCEB on other putative
mK+ channels, i.e., IKCa (KCa3.1) BKCa, and KATP channels. Because the protective effects of putative KATP24
and BKCa4 channel openers can be abolished by ROS scavengers, we similarly bracketed DCEB with a
matrix targeted dismutator of O2 − to assess the role of SKCa channel opening on O2 − production,
presumably by mitochondrial respiratory complexes. We used several approaches to furnish solid
evidence for the presence and functionality of SKCa channel proteins in the IMM of guinea pig isolated
cardiac mitochondria, and in isolated IMM.

2. Materials and methods
2.1. Isolated heart model

The investigation conformed to the Guide for the Care and Use of Laboratory Animals (NIH Publication
85‐23, revised 1996). Guinea pig hearts were isolated and prepared as described in detail4,25,26,27,28,29,30,31
with care to minimize IPC. These were pre-oxygenation, maintained respiration after anesthesia with
ketamine (50 mg/kg), and immediate aortic perfusion with cold perfusate. Hearts were instrumented
with a saline filled balloon and transducer to measure left ventricular pressure (LVP) and an aortic flow
probe to measure coronary flow (CF). Heart rate and rhythm were measured via atrial and ventricular
electrodes. Hearts were perfused at constant pressure with modified Krebs-Ringer's solution at 37 °C.
Heart rate (HR) and rhythm, myocardial function (isovolumetric LVP), coronary flow and venous pO2
were measured continuously. %O2 extraction, myocardial O2 consumption (MVO2) and cardiac efficiency
(HR·LVP/MVO2) were calculated. At 120 min reperfusion, hearts not isolated for mitochondria were
stained with 2,3,5-triphenyltetrazolium chloride (TTC) and infarct size was determined as a percentage
of ventricular heart weight.4,26,30

2.2. Cardiac fluorescence measurements

Either m[Ca2 +], NADH and FAD, or ROS (principally O2 −) was measured near continuously or
intermittently in the heart using one of four excitation (λex) and emission (λem) fluorescence spectra
described below. NADH and FAD were measured in the same heart; m[Ca2 +] and ROS were measured in
different subsets of hearts. A trifurcated fiber optic probe (3.8 mm2 per bundle) was placed against the
LV to excite and to record light signals at specific λ's using spectrophotofluorometers (SLM AmicoBowman and Photon Technology International). The incident polychromic light was filtered at 350 or
490 nm and recorded at 390/450 or 540 nm, respectively, to measure NADH25,28,30,32,33 and FAD30,32 tissue
autofluorescence. Alternatively, hearts assigned to measure Ca2 +, were loaded with 6 μM indo 1 AM for
30 min followed by washout of residual dye for 20 min. Ca2 + transients were recorded at the same
wavelengths as for NADH. Then hearts were perfused with MnCl2 to quench cytosolic Ca2 + to reveal noncytosolic [Ca2 +], mostly [mCa2 +].25,29,33 In other hearts, as reported earlier,4,26,27,31,33,34 dihydroethidium
(10 μM, DHE), which is used to measure intracellular superoxide (O2 −) level, was loaded for 30 min and
washed out of residual dye for 20 min. The LV wall was excited with light (λex 540 nm; λem 590 nm) to
measure a fluorescence signal that is primarily a marker of the free radical O2 −.31,35 DHE enters cells and
is oxidized by O2 − where it is converted to the labile cation, 2-hydroxyethidium (2-HE+), which causes a
red-shift in the EM light spectrum.36,37
Myocardial fluorescence intensity was recorded in arbitrary fluorescence units (afu) during 35 discrete
sampling periods throughout each experiment at a sampling rate of 100 points/s (100 Hz, pulse width
1 μs) during a 12 s triggered period for O2 − and for a 2.5 s triggered period for NADH and FAD, and
m[Ca2 +]. For each fluorescence study, no drug alone had any effect on background autofluorescence.
Signals were digitized and recorded at 200 Hz (Power LAB/16sp, Chart and Scope version 3.6.3. AD
Instruments) on G5 Macintosh computers for later analysis using specifically designed programs with
MATLAB (MathWorks) and Microsoft Excel software. All variables were averaged over the 2.5 or 12 s
sampling period.

2.3. Protocol

Hearts were infused with 3 μM DCEBIO (DCEB) for 10 min and ended 20 min before the onset of 30 min
global ischemia. DCEB is derived from the benzimidazolone class of compounds, which are known to
stimulate chloride secretion in epithelial .7,8,38 DCEB non-selectively opens KCa2.2 and 2.3
channels.7,18,19,20,21 In most hearts DCEB was bracketed either with 40 μM PAX (paxilline), a blocker of
BKCa channels,39 20 μM TBAP, a chemical dismutator of O2 − that can enter the matrix, 200 μM GLIB
(glibenclamide), a KATP channel blocker, or 100 nM TRAM (TRAM-34), an established blocker of IKCa
conductance channels.9 TRAM was selected because DCEB also opens IKCa channels.7,9,17,21 PAX, TBAP,
GLIB, or TRAM was given 5 min before, during DCEB perfusion, and for 5 min after stopping DCEB. In a
separate study DCEB was bracketed with 10 μM NS8593, a specific antagonist of SKCa channels22,23 to
compare with a no drug IR control. Drug exposure was discontinued 15 min before the onset of global
ischemia that lasted for 120 min. NS8593 caused a transient fall in systolic (and developed) LVP and an
increase in coronary flow. Additional studies (not displayed) showed that each of these drugs, except for
NS8593, given alone (without DCEB) for 20 min before ischemia elicited no appreciable effects and had
no different effect on IR injury than the drug-free controls.

2.4. Statistical analyses

A total of 155 isolated heart experiments were divided into 7 groups, a drug-free control, and DCEB
alone or plus NS8593, PAX, TBAP, GLIB or TRAM. Functional data were recorded from 12 to 15 hearts

per group. Infarct size was measured in a blinded manner in 8 hearts per group. NADH and FAD were
measured in approximately 6–8 hearts per group, O2 − in 5–7 hearts per group, and m[Ca2 +] in 6–8
hearts per group. Because functional studies showed trends that PAX, GLIB, or TRAM did not block
protective effects of DCEB, only four groups were compared in NADH and FAD experiments and three
groups were compared in O2 − and m[Ca2 +] experiments. All data were expressed as means ± standard
error of means. Appropriate comparisons were made among groups that differed by a variable at a
given condition or time, and within a group over time compared to the initial control data. Statistical
differences were measured across groups at specific time points (20, 50, 85, 145, and 200 min).
Differences among variables were determined by two-way multiple ANOVA for repeated measures
(Statview® and CLR ANOVA® software programs for Macintosh®); if F tests were significant, appropriate
post-hoc tests (e.g., Student–Newman–Keuls, SNK) were used to compare means. The incidence of
ventricular fibrillation (VF) vs. sinus rhythm per group, and the number of VFs per heart per group, were
determined by Fisher's Exact Test. In mitochondria K+ flux experiments drug treatments were compared
to control using the same statistical tests. Mean values were considered significant at P values (twotailed) < 0.05.

2.5. Isolation of cardiac mitochondria and inner mitochondrial membranes
(IMMs)

Mitochondria were freshly isolated from 25 guinea pig hearts by differential centrifugation as described
previously.5,6,34,40,41 To test mitochondrial viability and function in each preparation, the respiratory
control index (RCI, state 3/state 4) was determined under both pyruvate (P, 10 mM), and succinate (S,
10 mM) + rotenone (R, 4 μM) conditions. State 3 respiration was determined after adding 250 μM ADP.
Intact mitochondrial preparations were discarded if the RCI was less than 3 with succinate + R or less
than 9 with pyruvate.
To isolate fraction-enriched IMMs, isolated mitochondria were shocked osmotically by incubating in
10 mM phosphate buffer saline (PBS) (pH 7.4) for 20 min, and then in 20% sucrose for another 15 min.
The IMMs were sonicated for 30 s, 3 times, and then centrifuged at 8000 g for 10 min. The supernatant
containing sub-mitochondrial particles was fractionated using a continuous sucrose gradient (30% to
60%) and centrifuged at 80,000 g overnight in a SW28 rotor. The IMMs (enriched in the heavy fractions)
were suspended with the isolation medium without EGTA and centrifuged at 184,000 g for 30 min. The
final pellet enriched IMMs were suspended in isolation medium without EGTA and BSA and stored at
− 80 °C in small aliquots until use.

2.6. Enhancement of calmodulin-binding proteins from IMM

Calmodulin binds to SKCa channels so the calmodulin binding proteins obtained from the IMMs were
concentrated to enhance the sensitivity of detection of mSKCa channels by Western blotting and by mass
spectrometry. For calmodulin column chromatography (calmodulin-sepharose beads) the IMMs (5 mg
protein) were solubilized for 2 h at 4 °C in washing buffer, 200 mM KCl, 1 mM MgCl2, 200 μM CaCl2,
20 mM HEPES, pH 7.4, and 0.5% CHAPS with protease inhibitors. After centrifugation at 50,000 g for
30 min, the supernatant was applied to a calmodulin-sepharose column (10 by 1.5 cm) pre-equilibrated
with the solubilization buffer containing 0.1% CHAPS. The column was washed rapidly with 500 mL of
washing buffer as above. The proteins were eluted from the column by 2 mM EGTA in the elution buffer
(200 mM KCl, 20 mM HEPES, pH 7.4, 0.1% (w/v) CHAPS) after washing. The fractions collected were
concentrated and the proteins were separated by 2-D gel electrophoresis as follows.

2.7. Purification of SKCa channel proteins from IMM by isoelectric focusing

After isolating the IMM protein fraction (Sections 2.5 and 2.6) the first dimension of isoelectric focusing
(IEF) during 2-D gel electrophoresis was done in native gel buffer on an Immobilon Drystrips (Amersham)
with pH 4–7 gradient. The antibody was targeted to KCa2.3 (a.k.a. hSK3, KCN3, Osenses Pty, Ltd.). The
second dimension was done in a 10% Criterion® tris-SDS gel (Bio-Rad). Two identical gels were run at the
same time, with one used for transfer to nitrocellulose membrane for Western blot analysis, and the
other for silver staining and visualization.

2.8. IMM protein identification using electrospray LC/MS

IMM proteins (from Sections 2.5 and 2.6) were digested with trypsin and subjected to pH focusing into
10 fractions over pH 3–10 and each fraction was directly analyzed using a NP LC/ESI mass spectrometer
(Finnigan™ LTQ™ Ion Trap MS, Thermo Electron Corporation) to generate specific mass spectra typical
for a given protein. The instrument utilizes stepped normalized collision energy (SNCE) to improve
fragmentation efficiency over a wide mass range. This increases the capacity of a linear trap and the
accuracy and sensitivity of peptide detection in the fmol range. A mass database (NCBI Entrez Pubmed
protein) was searched for matching proteins and consequently the SKCa channel protein of interest was
tentatively identified in IMM.

2.9. Purification of intact mitochondria by Percoll gradient fractionation

To further verify localization of SKCa channel protein in an intact mitochondria preparation, the Percoll
gradient technique,42,43 with slight modifications, was used to purify intact mitochondria and immunohistochemical staining was utilized to identify SKCa channel protein. In brief, mitochondria isolated as
previously described5,6,34,40,41 were layered over 30% Percoll (in buffer A containing 450 mM mannitol,
50 mM HEPES, 2 mM EDTA, pH adjusted to 7.4 followed by addition of 50 mg BSA), and centrifuged at
95,000 g for 30 min. The lower dense band observed at the bottom of the tube, enriched in
mitochondria, was collected using a long tip glass pipette. Collected mitochondria (~ 4 mL) were
resuspended in the same buffer used to dilute Percoll, and centrifuged again at 6300 g. The resulting
pellet was suspended in the same buffer without BSA (buffer B) and re-centrifuged at 6300 g. The
mitochondrial pellet was resuspended in a small volume (~ 0.3 mL) of buffer B and stored until further
use.

2.10. Identification and localization of SKCa channel protein in purified
mitochondria

Immuno-histochemical staining with an anti‐SKCa antibody and confocal microscopy were used, in part,
to verify that SKCa channel protein resides in mitochondria. Briefly, mitochondria, isolated and purified
as described above (Section 2.9), were fixed onto poly-lysine coated coverslips. Mitochondrial structures
were then fixed using paraformaldehyde and membranes were permeabilized using Triton X-100 and
non-specific binding sites blocked by goat serum albumin. Coverslips were then incubated in solution
containing anti-KCa2.2 (anti-SK2, ETQMENYDKHVTYNAERS, Alomone Labs (1:1000 in 5% milk)) and antiANT (adenine nucleotide translocase, Invitrogen) antibodies for 30 min followed by three washes in
0.1 M PBS. Coverslips were then incubated in appropriate secondary antibodies (Alexa Flour 455 and
546 respectively, Invitrogen (1:3000 in 2% milk)) for another 30 min and were then transferred onto
microscope slides and visualized using a Leica confocal microscope (TCS SP5). Alternatively,

mitochondria were utilized for immuno-gold labeling to localize SKCa channel protein in individual
mitochondria.

2.11. Localization of SKCa channel protein by immuno-gold labeling and electron
microscopy

Immuno-electron microscopy (IEM) was used to localize SKCa protein in purified cardiac mitochondria
similar to the technique used by Douglas et al.44 to localize BKCa channel protein in mitochondria. The
final mitochondrial pellet, prepared as described above (Section 2.9), was resuspended in 500 μL
isolation buffer before centrifugation at 16,000 g for 20 min. The supernatant was discarded and an EM
fixative containing 0.1% glutaraldehyde + 2% paraformaldehyde in 0.1 M NaH2PO4 buffer (pH 7.4) was
added. After 1 h fixation at room temperature the pellet was gently detached from the tube with a 25 G
needle and processed following the protocols of Berryman and Rodewald.45 Pellets were washed
3 × 20 min in 0.1 M NaH2PO4 buffer containing 3.5% sucrose and 0.5 mM CaCl2, then rinsed in 0.1 M
glycine in NaH2PO4 buffer for 1 h on ice before returning to NaH2PO4 buffer. The pellets were cut into
1 mm cubes and then washed 4 × 15 min in 0.1 M tris maleate buffer + 3.5% sucrose, pH 6.5, at 4 °C
followed by post fixation in 2% Uranyl acetate (w/v) in tris buffer, pH 6, for 2 h at 4 °C; specimens were
then given a final rinse 2 × 5 min in Tris maleate buffer, pH 6.5. The specimens were then processed by
the progressive lowering-of-temperature method into Lowicryl K4M resin and the resin was polymerized
by UV irradiation. Ultrathin sections (70 nm) were cut onto Formvar/carbon coated grids. Immunolabeling was performed by floating grids on droplets of 0.1 M NaH2PO4 buffer containing 5% BSA (PBBSA), then incubating with rabbit polyclonal anti-KCa2.2 (anti-SK2, Alomone Labs) diluted 1:50 for 90 min,
or with the positive control mitochondrial marker, cytochrome c oxidase (anti-COX1: Complex IV,
subunit 1) mouse monoclonal antibody diluted 1:500. Non-immune rabbit polyclonal serum was used as
the negative control. This step was followed by 3 × 5 min washes in PB-BSA. The sections were then
incubated with goat anti-rabbit IgG, or goat anti-mouse IgG, conjugated to 10 nM colloidal gold46 for
90 min at room temperature, rinsed in distilled water, and then stained with 2% aqueous uranyl acetate.
Sections were examined in a JEOL JEM2100 TEM at 80 kV.

2.12. Purification/identification of SKCa channel protein by isoelectric focusing
(IEF) and Western blotting

Total mitochondrial protein, once isolated and purified as above (Section 2.9), was partitioned by IEF
and the resulting fractions were analyzed for mSKCa protein. Mitochondria (1 mg) were suspended in
3 mL electrophoresis buffer (0.1% w/v CHAPS, 0.1% w/v dodecyl maltoside, 5% (v/v) glycerol, 10 mg
dithiothreitol) and IEF was performed using the Micro-Rotofor system (BioRad, CA) for 4 h at 400 mA
constant current. The fractions thus obtained were collected and analyzed for SKCa protein by Western
blot using the anti-KCa2.2 (anti-SK2) antibody. Briefly, equal volumes of the 10 fractions obtained by IEF
were suspended in Laemmli buffer and resolved using sodium dodecyl sulfate‐polyacrylamide gel
electrophoresis (SDS-PAGE),47 as originally described by Laemmli,48 and transferred onto poly vinylidene
difluoride membranes using Transblot System (Bio-Rad) in 50 mM tricine and 7.5 mM imidazole transfer
buffer. Membranes were blocked with 10% non fat dry milk in tris buffered saline‐TBSt (25 mM Tris–HCl
at pH 7.5, 50 mM NaCl and 0.1% Tween 20) by incubating for 1 h followed by incubation in the antiKCa2.2 antibody (anti-SK2) solution overnight at 4 °C. After three washes with TBSt the membrane was
incubated with an appropriate secondary antibody conjugated to horseradish peroxidase for 3 h. After
five washes with TBSt the membrane was incubated in enhanced chemiluminescence detection solution

(ECL-Plus, GE-Amersham) and exposed to X-ray film for autoradiography. The protein fraction containing
the largest amount of SKCa was used for single channel recordings.

2.13. Enriching and incorporating mSKCa channel protein into lipid bilayers

Channel activity of the purified and enriched mSKCa protein was monitored by incorporating it into a
planar lipid bilayer, as previously described.49 Briefly, phospholipids were prepared by mixing
phosphatidyl-ethanolamine, phosphatidyl-serine, phosphatidyl-choline, and cardiolipin (Avanti Polar
Lipids) in a ratio of 5:4:1:0.3 (v/v). The phospholipids were dried under N2 and re-suspended in n-decane
to a final concentration of 25 mg/mL. The cis/trans chambers contained symmetrical solutions of 10 mM
HEPES, 200 mM KCl and 100 μM CaCl2 at pH 7.4. The cis chamber was held at virtual ground and the
trans chamber was held at the command voltages. SKCa protein was added into the cis chamber. The
effect of the SKCa blocker apamin, 100 nM, on channel activity was tested by adding it to the cis chamber
in the presence of 100 μM CaCl2. To test for Ca2 + dependence of the SKCa channel, [Ca2 +] was serially
increased (1, 50 and 100 μM) in the cis chamber. Currents were sampled at 5 kHz and low pass filtered
at 1 kHz using a voltage clamp amplifier (Axopatch 200B, Molecular Devices) connected to a digitizer
(DigiData 1440, Molecular Devices), and recorded in 1 min segments. The pClamp software (version 10,
Molecular Devices) was used for data acquisition and analysis. Additional analyses were conducted using
Origin 7.0 (OriginLab).

2.14. Matrix K+ measured in isolated mitochondria

Cardiac isolated mitochondria (0.5 mg protein/mL) were suspended in respiration buffer containing
130 mM KCl, 5 mM K2HPO4, 20 mM MOPS, 2.5 mM EGTA, 1 μM Na4P2O7, 0.1% BSA, pH 7.15 adjusted
with KOH. Buffer [Ca2 +] was less than 100 nM as assessed by the fluorescence dye indo 1. Matrix K+ was
monitored during state 4 respiration (200 μM ATP) with substrate Na-pyruvate (10 mM) in a cuvettebased spectrophotometer (QM-8, Photon Technology International, PTI) with light (λex 340 and 380 nm;
λex 500 nm) in the presence of the fluorescence dye PBFI (1 μM per mg/mL protein, Invitrogen) [50].
PBFI, in the acetylated methyl-ester (AM) form, was added to the mitochondrial preparation and
incubated at 25 °C for 20 min. After entering the matrix PBFI is retained in the matrix after it is cleaved
from the methyl-ester. During the last pellet wash the extra-matrix residual dye was washed out. Most
experiments were conducted in the presence of 500 μM quinine to block the mitochondrial K+/H+
exchanger (mKHE) and extrusion of the K+.50 In some experiments 0.25 nM valinomycin, a K+ ionophore,
was given to verify an increase in matrix K+ influx, and to be used as a reference for the change of K+
influx by DECB ± its antagonist UCL1684.

3. Results

3.1. DCEB protects isolated heart against IR injury

Spontaneous heart rate averaged 242 ± 13 beats/min before ischemia for all groups; this was not
statistically different at 120 min reperfusion for all groups (data not displayed). If ventricular fibrillation
(VF) occurred, it was only once within the first 5 min of reperfusion in any heart; all were converted to
sinus rhythm with intracoronary lidocaine. After 5 min reperfusion all hearts remained in sinus rhythm,
some with occasional pre-ventricular excitations. In data not displayed the incidence of VF on
reperfusion was CONTROL 100%, DCEB + TBAP 100%, DCEB 76%, DCEB + TRAM 72%, DCEB + PAX 77%,
and DCEB + GLIB 77% (all nonsignificant vs. control group).

Fig. 1, Fig. 2, Fig. 3, Fig. 4 show the marked degree of dysfunction or damage in the untreated control
group during and after global ischemia and the beneficial effects of PPC elicited by DCEB treatment
before ischemia. Developed LVP (Fig. 1A) and coronary flow (Fig. 1B) were reduced in each group after
ischemia compared to before ischemia, but these changes were much larger in the CONTROL and
DCEB + TBAP groups than in the other groups. Similarly, cardiac efficiency (Fig. 2A) was lower and infarct
size (Fig. 2B) was largest in the CONTROL and DCEB + TBAP groups than in all other groups. The drug
treatments before ischemia had no effects by themselves on any of the functional variables. These
figures indicate that these variables were markedly improved on reperfusion after treatment with DCEB
and that these improvements were reversed by TBAP, but not by PAX, TRAM, or GLIB.

Fig. 1. Improved (A) developed (systolic–diastolic) LV pressure and (B) coronary flow after preconditioning with
3 μM DCEB. Note that TBAP (synthetic superoxide dismutase mimetic) reversed the protective effects of DCEB
whereas antagonists of big (PAX, paxilline) and intermediate (TRAM) conductance KCa channels did not.

Fig. 2. A: Improved cardiac efficiency (developed LV pressure (mm Hg)·heart rate (beats/min)) / MVO2 (μL
O2·g− 1·min− 1) after preconditioning with DCEB. Note that TBAP reversed the protective effects of DCEB whereas
antagonists of big (PAX) and intermediate (TRAM) conductance KCa channels did not. B: Marked decrease in infarct
size after preconditioning with DCEB. Note that TBAP reversed the anti-infarction effect of DCEB whereas
antagonists of big (PAX) and intermediate (TRAM) conductance KCa channels and KATP channels (glibenclamide,
GLIB) did not.

Fig. 3. Improved redox state (A: NADH and B: FAD autofluorescence) after preconditioning with DCEB. Note the
inverse changes in NADH and FAD during ischemia and reperfusion and the more normalized responses in the
DCEB group. TBAP reversed the protective effects of DCEB whereas paxilline (PAX), an antagonist of big
conductance BKCa channels did not.

Fig. 4. Reduced (A) O2 − (DHE fluorescence) and (B) mitochondrial [Ca2 +] (indo 1 fluorescence) after
preconditioning with DCEB. Note the increases in these signals during ischemia and the slow decline during
reperfusion. DCEB attenuated the increase in these signals during ischemia and reperfusion and this was reversed
by TBAP.

There was no detectable change in NADH and FAD autofluorescence in any group by drugs given and
terminated before ischemia (Fig. 3A,B). NADH (Fig. 3A) remained higher at the end of ischemia and fell
less during reperfusion after treatment with DCEB; this was reversed by TBAP but not by TRAM. FAD
remained lower at the end of ischemia and rose less during reperfusion after treatment with DCEB (Fig.
3B); this was reversed by TBAP, but not by TRAM. In other experiments there was no detectable change
in NADH or FAD on reperfusion after DCEB + PAX or + GLIB treatment vs. DCEB alone.
DHE fluorescence (O2 − formation) (Fig. 4A) and indo 1 fluorescence (m[Ca2 +]) (Fig. 4B) rose markedly in
each group during the course of ischemia. TBAP caused a small, but insignificant, decrease in DHE
fluorescence before ischemia. TBAP reversed the effect of DCEB to reduce O2 − and m[Ca2 +] on
reperfusion. Other experiments (not shown) did not demonstrate detectable changes in ROS formation
or m[Ca2 +] on reperfusion after DCEB + PAX, + GLIB or + TRAM treatments vs. DCEB alone.
In companion experiments (Fig. 5A–D) the protective effects of DCEB were abolished or antagonized by
the SKCa channel antagonist NS8593, thus demonstrating that DCEB protected via activation of SKCa
channels. DCEB‐induced maintenance of developed LVP was completely blocked, while the maintenance
of coronary flow and the reduction of diastolic LVP and FAD oxidation by DCEB were all markedly
reversed by NS8593. NS8593 alone significantly depressed developed LVP when given before ischemia
and tended (non significantly) to slightly increase coronary flow, possibly indirectly due to reduced
ventricular compression; thus the small increase in flow (Fig. 5B) noted in the presence of DCEB is likely
due to NS8593 rather than to DCEB per se. Generally, cardiac depression before ischemia is
cardioprotective, but giving NS8593 with DCEB before ischemia, resulted in a worsening of contractile
function on reperfusion.

Fig. 5. Improved (A) developed LV pressure and coronary flow (B), and decreased diastolic LV pressure (C) and FAD
oxidation (D), after preconditioning with DCEB. Note that 10 μM NS8593 (a specific SKCa antagonist) abrogated
these protective effects of DCEB.

These studies demonstrated that DCEB had protective effects against cardiac IR injury mediated by the
SKCa channel, and that cardiac mitochondria appeared to be involved in mediating this protection.
Studies were then undertaken to isolate and identify the target of DCEB, the SKCa protein, in cardiac

isolated mitochondria and in IMM, and to verify the functionality of the protein in an artificial lipid
bilayer.

3.2. Isoelectric focusing and peptide sequences identify SKCa in isolated IMM

IMM protein, enhanced for calmodulin-binding residues, was separated by 2-D electrophoresis after
silver staining. Three peptide spots of approximately 70 kDa at pH 5.2–5.5 were detected as SKCa using
the anti KCa2.3 (anti-hSK3) (Fig. 6, panels A–C). Complementing this finding, a KCa2.3 protein was
identified by ESI-mass spectrometry from five matching peptides with an amino acid coverage of 10.73%
(Table 1). There was no evidence for peptides matching Na+/K+ ATPase or Ca2 + ATPase suggesting the
absence of sarcolemmal and t-tubular membranes in the mitochondrial fraction. The mass spectrum of
one of these peptide sequences is shown (Fig. 7). These results demonstrated that SKCa channels were
present in the IMM.

Fig. 6. Identity of small-conductance KCa channels in IMM from guinea pig heart. Top panel: Silver staining of
calmodulin affinity column-purified protein fractions after 2-D gel fractionation. The square indicates the area of
interest, which was magnified and is shown in the middle panel. The arrows indicate position of KCa2.3 proteins.
Bottom panel: Western blot with an antibody targeting SKCa (anti-hSK3) channel detection at 3 spots at 70 kDa
(arrow) between pH 5.2 and 5.5. Negative control was done by pre-incubating KCa2.3 antibodies with blocking
peptide (not shown).

Table 1. Protein coverage matched to an SKCa subunit 6 isoform by NP LC/SI mass spectrometry.

Letters in bold represent those peptides identified based on their MS/MS profiles. The list below the sequence
represents all peptides identified by mass spectrometry. The gray-filled sections of the bar above the sequence
represent the position of the identified peptides in the sequence. Also shown is the molecular weight and pI of the
protein. There are 4 peptides covering 10.89% of the total amino acids of this protein segment. Note that the mass
spectral analysis showed a 70% amino acid coverage in the calmodulin binding domain (CaMBD), a peptide
sequence just before (N terminus) the pore forming subunit 1, and the entire sequence of subunit 6.

Fig. 7. Identification of one peptide, FLQAIHQLRSVK (in CaMBD), from the data obtained using nano-LC/MS. The bions and y-ions are fragment masses of the above peptide upon its collision fragmentation. Peptides were
identified by searching the rodent subset of Uniprot databases. This protein was identified based on the 5
matching peptide sequences shown in Table 1.

3.3. Western blots of serially purified mitochondria demonstrate SKCa channel
protein

Mitochondria exhibited increasing band densities for both SKCa and ANT protein (Fig. 8) when enriched
by Percoll gradient serial purification. This furnished compelling Western blot evidence that SKCa channel
protein increases in abundance with ANT, which is present only in the IMM.

Fig. 8. Western blots of serially purified mitochondria showed increasing amounts of SKCa protein. Equal amounts
of protein were loaded in the gel. Total homogenate (lane 1, TH) showed least band intensity, followed by
mitochondria isolated by differential centrifugation (lane 2 RC); mitochondria purified further by Percoll gradient
purification (lane 3, PP) had the highest band intensity. Protein bands of SKCa are approximately 68 kDa. Purity of
mitochondria was followed by assaying the increased amount of ANT, along with SKCa, protein in their respective
purification fractions.

3.4. Immunochemistry and confocal microscopy identify SKCa channel protein in
mitochondria

Confocal microscopy was used to localize SKCa protein to intact mitochondria. Cardiac mitochondria
were visualized as stained by an antibody against ANT (green), and SKCa channel protein was visualized

using the anti-KCa2.2 (anti-SK2) antibody (red) (Fig. 9). Overlay of the two images (yellow) shows colocalization of SKCa and ANT proteins in cardiac mitochondria. Since ANT localizes only to the IMM, this
suggested that SKCa channel protein also localizes to the IMM.

Fig. 9. SKCa protein identified in isolated mitochondria and visualized by confocal microscopy. Overlay of the two
images (anti-ANT, green and anti-SKCa, red) demonstrates co-localization (yellow) of the SKCa protein in
mitochondria.

3.5. Immuno-gold labeling and EM show localization of SKCa channels in
mitochondrial matrix

To further confirm the presence and localization of the SKCa channels on the IMM, mitochondria were
visualized at high resolution using IEM. A large field EM view shows largely normal appearing cardiac
mitochondria with intact outer membranes and cristae (Fig. 10). Enhanced resolution of immuno-gold
labeled mitochondria shows gold particles attributed to SKCa channels (Fig. 11A,B) or cytochrome c
oxidase (COX) (Fig. 11C) within the matrix; in detailed examination of electron micrographs
approximately 50% contained at least 2 gold particles. Negative controls (Fig. 11D) (non-immune rabbit
polyclonal serum) showed no gold particles in any field. Fig. 8, Fig. 9, Fig. 11 confirm that SKCa channels
are located in mitochondria and most likely in the IMM.

Fig. 10. Electron micrograph of isolated mitochondria. Larger field view of untreated mitochondria shows largely
intact structural characteristics after isolation from guinea pig hearts.

Fig. 11. Immuno-electron microscopy of isolated cardiac mitochondria. A, B: SKCa protein as visualized in two
mitochondria; 50% of all viewed mitochondria exhibited gold labeling. Gold labeling was obtained by immuno-gold
secondary antibody conjugated to primary rabbit polyclonal anti-KCa2.2 (anti-SK2). C: Positive control was anticytochrome c oxidase (COX1) conjugated to goat anti-rabbit or mouse conjugated to colloidal gold; each
mitochondrion in a large field view exhibited at least two gold particles. D: Negative control was only secondary
polyclonal rabbit antibody conjugated to gold; there was no gold labeling of any mitochondria in any views.

3.6. Mitochondrial SKCa protein forms a functional channel

To test if purified mitochondrial SKCa protein forms a functional channel, SKCa protein, isolated as noted
above (Section 2.9), was incorporated into a planar lipid bilayer for electrophysiological measurements.
In the lipid bilayer, the SKCa protein exhibited robust activity in the presence of 100 μM [Ca2 +] (Fig. 12A).
Two conducting states with chord conductances of 230 and 730 pS were observed when recorded in an
ionic condition of equimolar 200 mM KCl. Adding apamin blocked the channel activity (Fig. 12B)

indicating that the functional channel formed by the mSKCa protein was inhibited by this SKCa channel
blocker. The mSKCa channel protein incorporated into the planar lipid bilayer also displayed Ca2 +‐
dependent activity (Fig. 13). The mSKCa channel exhibited increasing activity as [Ca2 +] was serially
increased from 1 to 100 μM. As shown, channel open probability (Po) increased from Po = 0.5 at 1 μM
[Ca2 +] to Po = 1.0 at 50 and 100 μM Ca2 +. A notable observation was also the [Ca2 +] dependent increase
in the number of conducting states. At 1 μM Ca2 + the predominant conductance was 180 pS; however,
at 50 and 100 μM Ca2 + multiple, larger conductances were revealed. Thus, as [Ca2 +] was increased the
mSKCa channel exhibited greater conducting states while at lower [Ca2 +], low conductance states
dominated. This observation is further supported by the existence of a smaller conductance channel of
70 pS which was detected, albeit infrequently, at 1 μM Ca2 + (Fig. 13, inset).

Fig. 12. mSKCa channel protein activity. Purified mitochondrial SKCa protein was incorporated into a planar lipid
bilayer and channel activity was recorded at a membrane potential of − 10 mV in the presence of 100 μM CaCl2.
Dotted lines denote zero current levels and downward deflections denote channel openings. A: Two primary
conductance states with chord conductances of 230 and 720 pS were observed under control conditions. The
current recording is also depicted in an expanded time scale. Corresponding all-point amplitude histogram is also
shown. B: Channel activity was blocked by adding 100 nM apamin.

Fig. 13. mSKCa channel sensitivity to [Ca2 +]. Channel activity of purified mitochondrial SKCa protein, incorporated
into the planar lipid bilayer, was recorded at a membrane potential of − 10 mV. [Ca2 +] was incrementally
increased; dotted lines denote zero current levels and downward deflections denote channel openings. The
corresponding all-point amplitude histogram is also shown. The predominant conductance was 180 pS when
channel activity was recorded in 1 μM [Ca2 +]. However, we have also observed, infrequently, a smaller conducting
state of 70 pS at 1 μM [Ca2 +]. A sample tracing is depicted in the inset in which the calibration for the x- and y-axis
is 200 ms and 1 pA, respectively; C and O denote the closed and open states, respectively.

3.7. DCEB‐induced increased matrix [K+] is blocked by UCL1684

The consequence of opening of SKCa channels to changes in mitochondrial matrix [K+] was also
determined. In isolated mitochondria the SKCa channel opener DCEB increased matrix [K+] in the
presence of quinine to inhibit KHE and thus counter K+ extrusion (Fig. 14A,B). The observed influx of K+
into the matrix was confirmed by similar K+ influx induced by the K+ ionophore valinomycin. The effect of
DCEB was blocked by UCL1684 (an SKCa blocker) but not by iberiotoxin (IBX) (a blocker of BKCa but not
SKCa channels) (Fig. 14B). The increase in matrix K+ uptake induced by DCEB and blocked by UCL1684
(Fig. 14), and the Ca2 + induced increases in K+ current and inhibition by apamin in lipid bilayers (Fig. 12,
Fig. 13) functionally linked DCEB's cardiac effects to SKCa channel presence and activity in cardiac
mitochondria.

Fig. 14. A: Sample time tracing showing effect of 30 μM DCEB in the presence of 500 μM quinine (KHE inhibitor) to
increase matrix K+ (PBFI fluorescence) in mitochondria isolated from a guinea pig heart. No change was observed
in the absence of quinine. The DCEB-induced increase in K+ flux was completely blocked by 100 nM UCL1684. Note
larger but similar effect of 1 nM valinomycin, a K+ ionophore, to DCEB. B: Summary effects (n = 10 mitochondrial
preparations) of DCEB, expressed as a % of valinomycin effect, on increasing matrix K+ in the presence of quinine.
This increase in K+ was blocked by SKCa channel blocker UCL1684 but not by 200 nM iberiotoxin (IBX), a blocker of
BKCa channels.

4. Discussion

Our results suggest a novel role for the SKCa channel in cardiac myocyte preconditioning, likely mediated
via altered mitochondrial function due to opening of SKCa channels located in myocyte mitochondrial
IMM (mSKCa). Our comprehensive experimental approach shows that the well-known SKCa (and IKCa)
channel activator DCEB preconditioned hearts and that this was fully reversible by bracketing DCEB with
the intra-matrix O2 − dismutator TBAP. Cardioprotective effects of DCEB were attributed specifically to
activation of SKCa channels and not to activation of KATP, IKCa, or BKCa channels because NS8593, but not
GLIB, TRAM, or PAX blocked its effects. DCEB increased K+ flux in isolated mitochondria and the purified
SKCa protein formed a functional channel when incorporated into lipid bilayers. Thus mSKCa channel
opening, similar to that of mKATP and mBKCa channel opening, appears to induce PPC by an as yet unclear
mechanism related to enhanced matrix K+ entry. Moreover, mitochondrial-derived O2 − is required to
initiate PPC by DCEB, because if O2 − is rapidly converted to downstream products the protection by
DCEB is lost.
Just as we supported our evidence that the SKCa channel is specifically involved in PPC of isolated hearts,
we sought to support specifically that the mSKCa channel was associated with cardioprotection. To
provide evidence that DCEB has protective effects mediated by mSKCa channels, it was necessary to
rigorously identify mSKCa protein in purified mitochondria, and specifically in the IMM. To do so we
utilized Western analysis and immuno-histochemistry, confocal microscopy, electron microscopy, and
mass spectrometry of purified mitochondrial proteins derived from IMM. Organelle location was
accompanied by channel functionality in isolated mitochondria and in lipid bilayers, thus supporting that
this channel may play a role in cardiac protection via a mitochondrial mechanism. Overall our study

indicates that the SKCa channel, localized in the cardiac cell IMM, mediates the effect of DCEB in
preconditioning of the heart via a mitochondrial mechanism related to mK+ flux and O2 − generation.
The dequalinium analogue, UCL1684, is known to block opening of apamin-sensitive SKCa channels in
mammalian cell lines.51 We support involvement of the mitochondrion in DCEB's PPC effect because
TBAP could block the protective functional effects of DCEB as well as block DCEB's effect to decrease
ischemia-induced levels of mCa2 + and of O2 −, presumably generated by complexes along the electron
transport system.52 Also, DCEB directly induced an increase in matrix K+ uptake. Moreover, since DCEB
had no significant effects on coronary flow (Fig. 1), automaticity, or contractility, this suggests DCEB had
no effect on endothelial/vascular or ventricular cell function. Overall, our results demonstrate the
marked cardioprotective effects after preconditioning with DCEB and implicate mSKCa channel opening
and generation of O2 −, or its products, as initiators and inhibitors of mitochondrial as well as cardiac
myocyte PPC.
The improvement in cardiac function by DCEB was accompanied by reduced formation of O2 −, reduced
m[Ca2 +], and improved redox state (more normal NADH and FAD levels) during both ischemia and
reperfusion. These cardioprotective effects of DCEB were blocked only by either TBAP or NS8593. We
suggest that initial formation of O2 − is essential for the triggering mechanism of PPC by mSKCa channel
activation. However, a downstream product of O2 −, e.g. H2O2, might actually mediate the protective
effects of DCEB. A similar dependence for O2 − has been observed for the mKATP channel opener
diazoxide,24 the BKCa channel opener NS1619,4 and volatile anesthetics.27,34 Drug lipophilicity with
mitochondrial membrane penetration may be an important common denominator for the activity of
drugs such as diazoxide, a putative mKATP channel agonist, and DCEB.

4.1. Distribution and function of Ca2 +‐sensitive K+ channels

The cell membranes of vascular smooth muscle, neural, and secretory cells contain large conductance
(200–300 pS) i.e. big Ca2 +-sensitive K+ (BKCa, aka maxi-KCa) channels that when opened produce
vasodilation, hyperpolarization, and secretion. BKCa channel opening is activated by increased [Ca2 +]i and
by cell membrane depolarization.53 Activation of BKCa over a range of [Ca2 +] is mediated at several
binding sites within the channel54 so that there is a wide range of [Ca2 +] responsiveness (Ka 10–
1000 μM).55 As K+ exits the cell with BKCa channel opening, this elicits cell membrane repolarization or
hyperpolarization, which in turn reduces Ca2 + entry by closing voltage-dependent Ca2 + channels. Altered
redox potential in smooth muscle56 suggested mitochondrial involvement. Xu et al.57 first furnished
evidence that BKCa channels are located in cardiac mitochondria.
The membrane bound, but non-voltage-gated, KCa channels, i.e., SKCa and IKCa11 are gated by Ca2 + and
other factors. SKCa (a.k.a. KCa2.1–2.3, KCNN1-3‐gene symbol) channels have characteristics that largely
differ from the BKCa channels i.e. small unitary conductance (10–30 pS), voltage independence with
activation only by Ca2 + at very low Ka (0.3 μM with steep I/V slopes), a sensitivity to apamin, heteromeric
assembly of the SKCa pore forming subunits with calmodulin (CaM), N rather than C terminal EF hand
domain for Ca2 + binding, and Ca2 + gating near the K+ selectivity filter.58 SKCas are unique in that
calmodulin forms an integral part of the channel, forming its Ca2 +-sensitive subunits.59 In the presence of
Ca2 +, two calmodulin binding domains form a dimer, which allows the channel to open.12
Antibodies against KCa2.2 and KCa2.3 were both used for immuno-staining and Western blot
characterizations in purified mitochondria and in the enriched IMM fraction, respectively. We found that

the identified protein was positive to both sets of antibodies. Because the sequence homology of the
SKCa family of channels (KCa2.1, KCa2.2, KCa2.3) is highly conserved,60 the commercial antibodies we used
might not have been selective enough to definitely identify the molecular identity of the specific mSKCa
isoform. But we did confirm that the purified mSKCa protein formed a functional channel by recording
channel activity after incorporating the protein into a planar lipid bilayer. The channel was inhibited by
apamin, a blocker of plasmalemmal membrane SKCa channels. However, the recorded conductance
states were higher than those reported for cell membrane SKCa channels, which are in the range of 10–
14 pS.11,58 The underlying cause of this discrepancy is unclear. It is possible that mSKCa channels have
biophysical attributes that are different from their cell membrane counterparts. In particular, the mSKCa
channels exhibited multiple conducting states that appear to be Ca2 +‐dependent. As the [Ca2 +]
increased, the channel's conductance also increased. Thus, at very low [Ca2 +], lower conductances may
be revealed that are closer to those reported for the plasmalemmal SKCa channel. In support of this, in
some recordings we infrequently observed a conductance of 70 pS at 1 μM [Ca2 +]. However, the
mechanism that underlies this Ca2 +‐dependent gating of the mSKCa channel has yet to be delineated.
Though it is premature to speculate on the structural homology between the mitochondrial and
plasmalemmal SKCa channels, based on our MS data and the Ca2 + sensitivity of the mSKCa channel, the
Ca2 +calmodulin‐binding domain and the S6 transmembrane region appear to be conserved. Indeed, the
block of channel activity by apamin showed that this mSKCa channel does share a pharmacological
property similar to the plasmalemmal SKCa.
However, the planar lipid bilayer experiments appear to indicate that the apamin binding site and the
Ca2 + binding site are both localized to the same side of the mSKCa channel. This was an unexpected
finding because apamin has been reported to be an external pore blocker that binds to the outer pore
region of the plasmalemmal SKCa channel,61 whereas the Ca2 + sensing region was believed to be on the
intracellular side, conferred by calmodulin that is constitutively bound to the C-terminus of the
channel.12 Consequently, our findings would imply that the position of the C-terminus in the mSKCa
channel differs from that in the plasmalemmal SKCa channel. Therefore, based on the sidedness of the
apamin effect and Ca2 + sensitivity, together with our observed biophysical properties, the mSKCa channel
may exhibit some functional and structural differences from the plamalemmal SKCa channel. Additional
experiments will be needed to confirm this possibility.
Our study represents the first conclusive report that identifies SKCa channels in cardiac myocyte
mitochondria. Their presence in the IMM would indicate that they have an important function in finetuning regulation of mitochondrial bioenergetics, perhaps via volume control, which is largely controlled
by K+ flux. In contrast, the voltage and Ca2 +-dependent BKCa channels may open only when ΔΨm is high
(state 4 respiration) or in response to a large imbalance in m[Ca2 +] or cytosolic [Ca2 +], much as BKCa
channels regulate cell membrane potential in excitable cells.
Three genes encode the SKCa family; all have been cloned, and the amino acid sequences predict
subunits similar to those in other K+ channels. Channel specificity resides in the C terminal domains
where each SKCa subtype interacts with the ubiquitous Ca2 + sensor CaM. This constitutive binding
domain is called CaMBD.62 Crystal structures show that SKCa + CaMBD contains two EF hand motifs
within each of the globular N and C terminal regions separated by a flexible linker.62 The C terminus is
required to establish the link of SKCa and CaM. Substitution of neutral amino acids for aspartate and
glutamate only in N terminus EF hand region blocks Ca2 + gating. This binding site is positioned just below
the K+ selectivity filter, which suggests that conformational changes near or even in the selectivity filter

itself function to gate SKCa channels. The 18 amino acid bee venom toxin apamin is highly selective for
SK2 by docking at the pore entrance and between the S3 and S4 loops.63
SKCa channels in neurons lie adjacent to Ca2 + stores and Ca2 + channels. In nerve cells SKCa channels play a
role in setting the intrinsic firing frequency, while BKCa channels regulate action potential shape and may
contribute to the unique climbing fiber response.15 The K+ flux mediated by BKCa and SKCa channels in
mitochondria may be differentiated by both their sensitivities to Ca2 + and dependence on ΔΨm during
states 3 and 4 respiration. Because there are many differences between these channels, the functional
effects of opening these channels are expected to differ; e.g., unlike BKCa, SKCa channel opening may
“fine tune” matrix K+ influx due to changing Ca2 + levels independent of changes in ΔΨm during the
variable rate of oxidative phosphorylation.

4.2. mSKCa channel opening triggers preconditioning via ROS

The presence of both SKCa and BKCa channels in cardiac myocyte IMM indicates a functional importance
for these channels during excess mCa2 + loading; moreover their endogenous opening during IPC, or as a
pharmacological therapy, may be an important trigger for cardioprotection. It is unclear if these drugs
actually open these K+ channels directly to elicit preconditioning, or if they themselves alter
mitochondrial bioenergetics (as mild uncouplers of oxidative phosphorylation), which mediates the
memory of preconditioning by other downstream effectors. Although the mitochondrial preconditioning
effect of DCEB appears to require both mSKCa channel opening and generation of O2 −, these factors are
not effectors of PPC as the DCEB and TBAP are washed out before ischemia.
There is ample evidence that O2 − is necessary to trigger PPC by mK+ channel openers but the
mechanism of O2 −, and its products or reactants, in mediating PPC is unknown. An increase in redox
state (increased NADH, decreased FAD) at a given [O2] can result in increased O2 − generation.64 O2
derived free radical “bursts” are known to occur during reperfusion when excess O2 is available. Our
group4,26,27,33 and others35,65 have shown, moreover, that ROS are also formed in excess during ischemia
before reperfusion when tissue O2 tension decreases, the redox state increases and then decreases, and
cytochrome c oxidase (complex IV) activity is low.66 The putative mKATP channel opener diazoxide67
mimicked IPC on reducing infarct size and the ROS scavengers, N-acetylcysteine68 or N-mercaptopropionyl-glycine,24 blocked the preconditioning effect of diazoxide. It has been suggested that mKATP
channel opening can cause a small increase in ROS formation,69 which may trigger cardioprotection
through activation of protein kinases. Conversely, ROS have also been proposed to activate the
sarcolemmal KATP channel by modulating its ATP binding sites as this effect is blocked by GLIB or by ROS
scavengers.70 Others have proffered that ROS produced during IPC may afford cardioprotection on
reperfusion directly, or via a feed forward mechanism for KATP channel-induced ROS production.71,72
In the present study evidence that the protective effect of DCEB is mediated by ROS is indicated by
reversal of the protection in the presence of TBAP. O2 − or OH , or even non-radical reactants like H2O2
or ONOO− (formed in the absence or presence of NO , respectively) may actually produce the
preconditioning responses, but O2 − appears necessary to initiate the response. It is also possible that
mSKCa, mBKCa, and or mKATP channel activation is altered by ROS as a feed forward controller of
mitochondrial function. Enhanced electron transfer before ischemia may minimize respiratory
inefficiency, i.e., reduced matrix contraction and improved respiration on reperfusion. mSKCa channel
opening, like mKATP channel opening, and indeed opening of any mK+ channel, could induce PPC by

mildly enhancing O2 − generation, which stimulates enzymatic pathways that help to protect the cell
from IR injury. Interestingly, we observed that O2 − dismutation by TBAP blocked protection by DCEB.
When DCEB was given alone or with any of the inhibitors, it had no direct detectable effect on
mechanical function or mitochondrial bioenergetics (redox state, O2 − levels) in isolated hearts. In our
related study4 neither NS1619 nor its antagonist PAX showed any direct effect on measured variables. In
the ex vivo, intact heart perfused with adequate substrates and O2, mitochondria are mostly respiring in
the non-resting state 3, so small changes in O2 − between states 3 (ample ADP) and 4 (consumed ADP)
respiration cannot be observed. However, in isolated cardiac mitochondria we reported that low, but
not high, concentrations of the BKCa channel opener NS1619 can increase resting state 4 respiration and
ROS generation while maintaining IMM potential (∆Ψm).6
We propose similarly that DCEB, like NS1619, increases intramatrix K+, which is replaced immediately
with H+ via KHE. We suggest that at low concentrations of these openers a transient increase in matrix
acidity, i.e., via a proton leak, stimulates respiration but maintains ΔΨm so that a greater amount of O2 −
is generated at mitochondrial respiratory complexes due to impaired electron transport. O2 − itself, or a
reactant, may in turn stimulate downstream-induced phosphorylation pathways fostering K+ channel
opening as necessary when ischemia occurs. The net effect could be preservation of mitochondrial
bioenergetics during ischemia as evidenced by better maintenance of the reduced state (high NADH and
low FAD) and smaller increases in O2 − generation and less m[Ca2 +] overload. This could lead to better
preservation of oxidative phosphorylation and ATP turnover leading to better utilization of ATP on initial
reperfusion after ischemia.

4.3. Putative mechanism of mitochondrial K+ flux on mitochondrial protection
during IR injury

BKCa and SKCa channel openers appear to have a profound ability to induce PPC but the mechanism is
unclear. It is possible that brief ischemia as in IPC causes a slight elevation of mCa2 + that induces mSKCa
and mBKCa channel opening and, like mKATP channel opening, leads to partial dissipation of ∆Ψm and or
matrix swelling as a protective mechanism against subsequent IR injury. It is now clear that K+ is required
for optimal functioning of oxidative phosphorylation because matrix K+ flux largely regulates matrix
volume and can modulate ∆Ψm.73,74,75 Trans-matrix K+ flux can also modulate ROS production.6 mSKCa
channels, like mBKCa channels,57,76 may act to modulate matrix volume during times of increased matrix
Ca2 + load, such as occurs during IR injury25,29 Xu et al.57 first suggested that opening mBKCa channels to
enhance matrix K+ influx is an important factor in mitigating IR injury in a manner similar to mKATP
channels. They proposed57 that the function of mBKCa channels was to improve the efficiency of
mitochondrial energy production.
As with the other two K+ channels reported in mitochondria, KATP and BKCa, once the K+ channel is
opened the increase in K+ uptake leads to changes in the matrix as described by Garlid et al. and Beavis
et al.77,78 Electrogenic H+ efflux driven by the respiratory chain is balanced by electrophoretic K+ influx. If
this were uncompensated, it would cause a very large increase in matrix pH of about 2 pH units. Partial
compensation is provided by electroneutral uptake of substrate anions, such as phosphate. The
compensation is partial because the concentration of phosphate in the cytosol is much lower than that
of K+, and this imbalance leads to matrix alkalinization.79,80 Matrix alkalinization now releases the K+/H+
antiporter from inhibition by matrix protons,75 causing K+ efflux to increase in response to increased K+

uptake until a new K+ steady state is achieved. An increase in futile K+ cycling is believed to produce mild
uncoupling78 and regulates mitochondrial bioenergetics and ROS emission.
Although mKCa channels likely play a role in regulating mitochondrial bioenergetics, it is unknown how
opening of these channels leads to more normalized NADH/FAD levels, reduces excess ROS, and
decreases Ca2 + loading during IR. Just as the existence and function of the mKCa channel in IMM on
mitochondrial respiration is unclear, so is the mechanism of K+ influx via mKATP channels in
IMM.73,76,81,82,83,84 For the KATP channel it was proposed that its opening depolarizes the IMM to cause
uncoupling and hasten respiration.76,81,85 Subsequent ischemia would then reduce the driving force for
Ca2 + influx through the mCa2 + uniporter; this could attenuate mCa2 + overload86,87 so that energized
mitochondria on reperfusion would perform more efficiently. Indeed the putative mKATP channel opener
diazoxide is reported to reduce the rate of mCa2 + uptake by depolarizing the IMM and decreasing the
driving force for mCa2 + entry,76,81,85 although this could be due to respiratory inhibition distinct from KATP
channel opening.73,88
Garlid's group,73,88 moreover, proposed that the physiological role of potential mK+ channels is control of
matrix volume rather than dissipation of ΔΨm and uncoupling. They postulated that matrix swelling by K+
uptake is caused by concomitant uptake of Cl− and water by osmosis. But subsequent activation of mKHE
may only slightly dissipate the proton gradient (∆μH) by increasing matrix acidity (proton leak) without
significantly altering ΔΨm.74,88 In turn, mitochondrial swelling might optimize mitochondrial function
because partial uncoupling was seen to improve efficiency of oxidative phosphorylation.89 More
specifically, during hypoxia matrix K+ influx appears to maintain a normal matrix volume, which
preserves a narrow intermembrane space and helps to facilitate energy transfer to ATP-utilizing sites, to
reduce outer membrane permeability to nucleotides, and to slow ATP hydrolysis.73,74,75 The end result of
mSKCa channel opening, like mKCa channel opening, may be to improve mitochondrial efficiency, reduce
m[Ca2 +] and ROS production, and thereby to protect overall mitochondrial function during IR.

4.4. Interrelationship and timing of mCa2 + loading, ∆Ψm, redox state, and ROS
during cardiac IR injury

Prolonged mitochondrial ischemia is marked by the following: decreasing ∆Ψm, an oxidized redox state,
excess ROS, matrix contraction, and increasing mCa2 + loading. Ca2 + overload due to leaky IMM could
impede normal electron transfer so that greater amounts of ROS are produced during IR. Alternatively,
ROS can damage membranes by lipid peroxidation; this can hamper selective permeability to ions and
allow cytosolic and mCa2 + uptake as a result of increased reverse mode sarcolemmal Na+/Ca2 + exchange
(NCE).90,91

Our studies in the intact heart model show an interrelationship between O2 − produced, redox state, and
mCa2 + influx during ischemia. Continuously measured NADH and O2 − changed together during ischemia
as well as during reperfusion. Ischemia-induced rises in NADH,4,25,28,30,33 ROS,4,26,27,33 and m[Ca2 +]4,25,29,33
returned closer to normal values on reperfusion after PPC. These effects were reversed by ROS
scavengers or by blocking sarcolemmal KATP and/or mKATP channel opening with GLIB or 5hydroxydecanoate.27,29 Preconditioning also led to reduced ROS generation and improved ATP synthesis
in isolated mitochondria.92 These studies suggest that temporary exposure to distinct cardioprotective
drugs before ischemia causes ROS-dependent changes in mitochondrial bioenergetics that initiates a
preconditioning effect. mKCa is likely to be activated endogenously as matrix Ca2 + rises in response to an

increase in Ca2 + load, such as occurs during ischemia; opening these channels pharmacologically before
ischemia may lead to added protection.

4.5. Summary and limitations

We have furnished ample evidence for the presence of SKCa channels in purified mitochondria and in
IMM from cardiac cells, for the functional effects of the IKCa and SKCa channel opener DCEB on K+ flux in
isolated mitochondria, and for the channel conductance of SKCa proteins incorporated into planar lipid
bilayers. Moreover, we have demonstrated that SKCa channel opener DCEB initiates cardiac PPC as
shown by marked metabolic and functional improvements during reperfusion. These are supported by
better preserved reduced redox state (high NADH and low FAD), decreased O2 − production, reduced
mCa2 + loading during IR, and reduced infarct size. The protection by DCEB was blocked by dismutation
of O2 − with TBAP and by the SKCa antagonist NS8593. It is possible that mSKCa channel opening induces a
mild proton leak due to mKHE, which accelerates respiration, but maintains ∆Ψm, so that small amounts
of generated O2 − trigger a downstream protective pathway.
All of the K+ channel agonists may converge on a pathway that stimulates a small amount of ROS. That
TBAP blocks protection by this drug and that mitochondria are a major source of ROS, suggest that DCEB
exerts its effects primarily in mitochondria. Only relative changes in NADH and FAD levels and ROS
formation can be assessed in our model. We did not test if the mSKCa channel is open during IR injury,
although we have preliminary evidence that the BKCa channel is open during reperfusion.93 It is plausible
that some factors that induce preconditioning, like small increases in ROS or m[Ca2 +], are the same
factors, albeit at much greater levels, that cause IR damage. Thus the individual stages of triggering,
activation and end-effect must be well delineated to unravel the complicated mechanism underlying the
cardiac protection afforded by preconditioning.
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